Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Icon (NASDAQ:ICLR) in the last three months. In the table below, you'll find a summary of their ...
ICON expects market conditions to remain similar through year-end, assuming persistent cancellation rates and mixed timing on biotech conversions. The company raised its full year revenue guidance to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results